Skip to main content
SpringerLink
Log in

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14–22.

    Article  CAS  Google Scholar 

  2. Kilpivaara O, Levine RL . JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia 2008; 22: 1813–1817.

    Article  CAS  Google Scholar 

  3. Kralovics R . Genetic complexity of myeloproliferative neoplasms. Leukemia 2008; 22: 1841–1848.

    Article  CAS  Google Scholar 

  4. Mullighan CG . TET2 mutations in myelodysplasia and myeloid malignancies. Nat Genet 2009; 41: 766–767.

    Article  CAS  Google Scholar 

  5. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289–2301.

    Article  Google Scholar 

  6. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930–935.

    Article  CAS  Google Scholar 

  7. Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E et al. Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 2007; 110: 375–379.

    Article  CAS  Google Scholar 

  8. Shigesada K, van de Sluis B, Liu PP . Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Oncogene 2004; 23: 4297–4307.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by INSERM, INCa, the Fondation de France and the Ligue Nationale Contre le Cancer. We thank William Vainchenker for critical reading of the manuscript.

Author information

Authors and Affiliations

  1. INSERM E210, Hôpital Necker-Enfants Malades,

    L Couronné & O A Bernard

  2. Université René Descartes, Paris, France

    L Couronné & O A Bernard

  3. Laboratoire de Cytogénétique, CHU, Bordeaux, France

    E Lippert

  4. Laboratoire de Génétique Médicale, CHU, Lille, France

    J Andrieux

  5. Service d'Hématologie Biologique, CHU Cochin, Paris, France

    O Kosmider

  6. Université René Descartes, Paris, France

    O Kosmider

  7. Laboratoire de Cytogénétique, Hôpital Necker-Enfants Malades, Paris, France

    I Radford-Weiss

  8. Génétique Oncologique, Centre H Becquerel, Rouen, France

    D Penther

  9. Génétique des Hémopathies, CHU, Toulouse, France

    N Dastugue

  10. Laboratoire de Cytogénétique, CHU, Dijon, France

    F Mugneret

  11. Laboratoire de Cytogénétique, CHU La Timone, Marseille, France

    M Lafage

  12. Laboratoire de Cytogénétique, CHU, Limoges, France

    N Gachard

  13. Laboratoire de Cytogénétique, CHU, St-Etienne, France

    N Nadal

  14. Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière,

    F Nguyen-Khac

  15. INSERM, U872, Paris, France

    F Nguyen-Khac

  16. Université Pierre et Marie Curie-Paris 6,

    F Nguyen-Khac

Authors
  1. L Couronné
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Lippert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Andrieux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O Kosmider
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Radford-Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Penther
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Dastugue
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Mugneret
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Lafage
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. N Gachard
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. N Nadal
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. O A Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. F Nguyen-Khac
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Groupe Francophone de Cytogénétique Hématologique

Corresponding author

Correspondence to F Nguyen-Khac.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couronné, L., Lippert, E., Andrieux, J. et al. Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias. Leukemia 24, 201–203 (2010). https://doi.org/10.1038/leu.2009.169

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2009.169

  • Springer Nature Limited

This article is cited by

Search

Navigation